filmov
tv
Conversation with MPN Specialists- Focus on ET/PV
Показать описание
MPN Advocacy & Education International spoke with Dr. Andrew Kuykendall, Moffitt Cancer Center, and Dr. Angela Fleischman, UC Irvine, as they answered attendees' questions
1:52:43
Conversation with MPN Specialists: Focus on Myelofibrosis
1:42:53
Conversation with MPN Specialists- Focus on MF
1:28:01
Conversation with MPN Specialists- Focus on ET/PV
1:58:02
Conversation with MPN Specialists- Focus on Polycythemia Vera
2:01:47
Conversation with MPN Specialists: Focus on Essential Thrombocythemia
1:35:27
A Conversation with an MPN Specialist: Focusing on Myelofibrosis
1:30:12
Conversation with an MPN Specialist: Focusing on Essential Thrombocythemia
0:56:04
A Conversation with an MPN Specialist: Essential Thrombocythemia
1:58:40
Conversation with MPN Specialists: Ask All of Your Questions
1:42:23
A Conversation with an MPN Specialist: From Diagnosis to Current Treatment Options
1:11:55
A Conversation with an MPN Specialist: Myelofibrosis
0:59:29
A Conversation with an MPN Specialist: Symptom Management and Lifestyle Changes
1:32:37
Conversation with an MPN Specialist: Everything You Should Know About Clinical Trials
0:57:26
A Conversation with an MPN Specialist: Questions You Should Be Asking Your Hematologists
1:41:17
Conversation with MPN Specialists: MPN Symptom Burden Management
2:00:34
Conversation with MPN Specialists
1:51:15
Conversation with an MPN Specialist: New Combinations and Novel Approaches in the Future of MPNs
1:36:21
A Conversation with an MPN Specialist: MPN Symptom Management
0:58:06
A Conversation with an MPN Specialist: What You Should Know About JAK Inhibitors/Non-JAK Inhibitors
2:17:45
Conversation with MPN Specialists - #2
1:07:13
A Conversation with an MPN Specialist: Financial Toxicity and Value-Based Care
1:35:11
A Conversation with MPN Specialists: Pediatric & Young Adults with MPNs
0:50:19
Conversation with an MPN Specialist: Summer Updates
1:04:42
A Conversation with MPN Specialists: A Summary of Clinical Trials, Drugs, and What They Do
Комментарии